A detailed history of Triton Wealth Management, Pllc transactions in Abb Vie Inc. stock. As of the latest transaction made, Triton Wealth Management, Pllc holds 1,376 shares of ABBV stock, worth $246,579. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,376
Previous 1,435 4.11%
Holding current value
$246,579
Previous $246,000 10.16%
% of portfolio
0.15%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$163.84 - $199.33 $9,666 - $11,760
-59 Reduced 4.11%
1,376 $271,000
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $928 - $1,084
-6 Reduced 0.42%
1,435 $246,000
Q1 2024

Apr 25, 2024

BUY
$159.82 - $182.1 $32,123 - $36,602
201 Added 16.21%
1,441 $262,000
Q4 2023

Jan 24, 2024

BUY
$137.6 - $154.97 $170,624 - $192,162
1,240 New
1,240 $192,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Triton Wealth Management, Pllc Portfolio

Follow Triton Wealth Management, Pllc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Triton Wealth Management, Pllc, based on Form 13F filings with the SEC.

News

Stay updated on Triton Wealth Management, Pllc with notifications on news.